|
|
|
Insider
Information: |
Broom Colin Md |
Relationship: |
Director |
City: |
Exton |
State: |
PA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
36,523 |
|
Indirect Shares
|
72,849 |
|
|
Direct
Value |
$14,383 |
|
|
Indirect Value
|
$28,688 |
|
|
Total
Shares |
109,372 |
|
|
Total
Value |
$43,071 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-39.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Viropharma Inc |
VPHM |
VP & Chief Scientific ... |
2014-01-24 |
0 |
2008-09-12 |
0 |
Premium* |
|
NPS Pharmaceuticals Inc |
NPSP |
Director |
2015-02-21 |
0 |
2013-02-07 |
0 |
Premium* |
|
Nabriva Therapeutics AG |
NBRV |
Director |
2022-08-02 |
36,523 |
2018-06-22 |
72,849 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
42 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VPHM |
Viropharma Inc |
VP & Chief Scientific Officer |
|
2011-12-23 |
4 |
OE |
$1.84 |
$32,200 |
D/D |
17,500 |
36,939 |
0 |
- |
|
VPHM |
Viropharma Inc |
VP & Chief Scientific Officer |
|
2012-12-10 |
4 |
OE |
$5.91 |
$651,490 |
D/D |
74,999 |
52,666 |
0 |
- |
|
VPHM |
Viropharma Inc |
VP & Chief Scientific Officer |
|
2012-12-24 |
4 |
OE |
$1.84 |
$32,200 |
D/D |
17,500 |
55,167 |
0 |
- |
|
VPHM |
Viropharma Inc |
VP & Chief Scientific Officer |
|
2012-12-27 |
4 |
OE |
$1.84 |
$18,400 |
D/D |
10,000 |
30,167 |
0 |
- |
|
VPHM |
Viropharma Inc |
VP & Chief Scientific Officer |
|
2014-01-08 |
4 |
OE |
$1.84 |
$740,574 |
D/D |
142,142 |
156,192 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
Director |
|
2014-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,188 |
24,313 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Director |
|
2019-08-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,750 |
135,901 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Director |
|
2020-08-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,750 |
260,000 |
0 |
- |
|
VPHM |
Viropharma Inc |
VP & Chief Scientific Officer |
|
2008-09-12 |
4 |
S |
$14.21 |
$361,263 |
D/D |
(25,353) |
12,103 |
0 |
- |
|
VPHM |
Viropharma Inc |
VP & Chief Scientific Officer |
|
2010-09-09 |
4 |
S |
$13.25 |
$225,867 |
D/D |
(17,040) |
15,113 |
0 |
- |
|
VPHM |
Viropharma Inc |
VP & Chief Scientific Officer |
|
2010-09-10 |
4 |
S |
$13.25 |
$104,692 |
D/D |
(7,900) |
15,113 |
0 |
- |
|
VPHM |
Viropharma Inc |
VP & Chief Scientific Officer |
|
2010-09-13 |
4 |
S |
$13.25 |
$67,207 |
D/D |
(5,060) |
15,113 |
0 |
- |
|
VPHM |
Viropharma Inc |
VP & Chief Scientific Officer |
|
2012-12-10 |
4 |
S |
$24.07 |
$1,805,016 |
D/D |
(74,999) |
37,667 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Director |
|
2019-08-21 |
4/A |
S |
$2.07 |
$21,066 |
D/D |
(10,177) |
125,724 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Director |
|
2020-08-20 |
4 |
S |
$0.65 |
$7,165 |
D/D |
(11,064) |
248,936 |
0 |
% |
|
NBRV |
Nabriva Therapeutics AG |
Director |
|
2021-08-02 |
4 |
S |
$1.20 |
$637 |
D/D |
(531) |
41,862 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Director |
|
2022-08-02 |
4 |
S |
$0.19 |
$1,015 |
D/D |
(5,339) |
36,523 |
0 |
- |
|
42 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|